Okomera is excited to share that Silvère Lucquin will become the new Chief Executive Officer starting on September 8, 2025. He will take over from Sidarth Radjou, who has chosen to explore new career paths. The company is grateful for Sidarth’s leadership and vision during his time with the company and wishes him all the best in his future plans.
Health Technology Insights: RazorMetrics Names Akshay Bhandari GM and CFO
Silvère has over ten years of experience in the Medtech and Life Science tools industries and has a proven ability to help companies grow at the intersection of healthcare and innovation. Most recently, he served as Chief Operating Officer at Ganymed Robotics, where he helped shape the company’s strategy, led its rapid growth, and managed important areas such as human resources, business planning, industrial partnerships, and product development.
Before joining Ganymed Robotics, Silvère worked at Aditlys Medical, where he was in charge of the company’s spin-off and early organizational development. He was also the first employee at CorWave, leading major development projects and supporting the company through two fundraising rounds, Series A and B. His hands-on experience has prepared him well to handle the challenges of growing innovative health technology companies.
Health Technology Insights: Janus Health Joins Cipher Collective AI Health Technology Partnership Program
Silvère is an engineer by training, holding degrees from École Polytechnique in France and Imperial College London. He also earned an MBA from INSEAD, combining strong technical skills with advanced business knowledge. This background makes him well-prepared to guide Okomera as it expands its impact in cancer research through advanced technology.
Richard Eglen, Chair of Okomera’s Board, is enthusiastic about Silvère’s appointment, saying his strategic thinking and leadership qualities make him the right person to lead the company into its next stage of growth. Silvère himself is excited about the opportunity ahead, noting that Okomera is at a critical point and he is looking forward to working with the team to build on past successes, strengthen collaborations, and speed up the development of innovative solutions for cancer researchers around the world. With Silvère Lucquin leading the company, Okomera is committed to continuing its mission of transforming cancer research through innovation and supporting the global scientific community in the fight against cancer.
Health Technology Insights: MedeAnalytics Appoints Justin L. Neece as Chief Growth Officer
To participate in our interviews, please write to our HealthTech Media Room at sudipto@intentamplify.com
